Medtronic, Inc. (NYSE: MDT) and Bayer Diabetes Care, a division of Bayer HealthCare LLC and a member of the Bayer Group (NYSE: BAY), announced an alliance to distribute and co-market a new blood glucose meter for Medtronic patients outside the United States beginning in Canada and Europe. The new meter, based on Bayer's Contour® meter platform, will wirelessly transmit blood glucose test results directly to MiniMed Paradigm® insulin pumps and Guardian® REAL-Time continuous glucose monitoring (CGM) systems. Wireless communications make data entry easier and more convenient for patients.
Medtronic And Bayer Diabetes Care Announce Alliance To Provide Blood Glucose Meter To Medtronic Patients Outside The United States
0 comments :
Post a Comment
Click to see the code!
To insert emoticon you must added at least one space before the code.